|
Status |
Public on Nov 03, 2014 |
Title |
T215P_eh0026 |
Sample type |
RNA |
|
|
Source name |
BALB/c_PR8 NS1 T215P variant_lung
|
Organism |
Mus musculus |
Characteristics |
strain background: BALB/c infected with: Influenza A virus PR8 NS1 T215P variant time point: 5 dats after infection tissue: lung
|
Growth protocol |
BALB/c mice were infected with Influenza A virus PR8 wt and PR8 NS1 T215P variant (100PFU). PBS inoculated mice served as control
|
Extracted molecule |
total RNA |
Extraction protocol |
On d5 after Infection, lungs were collected in Trizol. RNA isolation was done using Trizol method and PureLink RNA Mini kit (Ambion)
|
Label |
Biotin
|
Label protocol |
RNA was amplified using the NuGEN Ovation Pico WTA V2 system and then labeled with the NuGEN Encore Biotin Module.
|
|
|
Hybridization protocol |
Labeled targets were hybridized on the mogene2st array and processed using the Affymetrix system.
|
Scan protocol |
Scanning uses the Affymetrix scanner
|
Data processing |
The data were analyzed with Partek Genomics Suite 6.6 by the RMA method.
|
|
|
Submission date |
Oct 08, 2014 |
Last update date |
Nov 04, 2014 |
Contact name |
David Finkelstein |
E-mail(s) |
david.finkelstein@stjude.org
|
Phone |
9014953931
|
Organization name |
St Jude Children's Research Hospital
|
Department |
Computational Biology
|
Street address |
332 N. Lauderdale St.
|
City |
Memphis |
State/province |
TN |
ZIP/Postal code |
38105 |
Country |
USA |
|
|
Platform ID |
GPL16570 |
Series (1) |
GSE62169 |
NS1-mediated inhibition of c-Abl results in acute lung injury and priming for bacterial co-infections; insights into 1918 H1N1 pandemic |
|